The Boston University Center for Molecular Discovery (BU-CMD) is an integrated infrastructure for the discovery of new small molecule chemical probes, therapeutic leads, and therapeutic target pathways.
The operations of BU-CMD consist of synthetic chemistry, high-throughput screening and biology (HTS), medicinal chemistry, and translational investigations.
The BU-CMD builds upon the foundation originally established by the Center for Chemical Methodology and Library Development at Boston University (CMLD-BU).
Funded by the National Institute of General Medical Sciences (NIGMS)
from 2001-2014, the CMLD-BU focused on the production of novel chemical libraries of unprecedented complexity for biological screening,
publishing new protocols and methodologies for library synthesis, and providing chemical libraries to members of the biological research community
to use as research tools in collaborative efforts.